Liquid chromatography-tandem mass spectrometry assay for the EGFR inhibitor pelitinib in plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 934, Issue , 2013, Pages 22-25

  Luethi, Dino ^a   Durmus, Selvi ^b   Schinkel, Alfred H ^b   Schellens, Jan H M ^a,b   Beijnen, Jos H ^a,b,c   Sparidans, Rolf W ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

Bioanalytical assay; EGFR inhibitor; FVB mouse; LC MS MS; Pelitinib

Indexed keywords

BIOANALYTICAL ASSAYS; EGFR INHIBITOR; FVB MOUSE; LC-MS/MS; PELITINIB;

AMINO ACIDS; ELECTROSPRAY IONIZATION; LIQUID CHROMATOGRAPHY; MAMMALS;

MASS SPECTROMETRY;

ACETONITRILE; ERLOTINIB; FORMIC ACID; METHANOL; PELITINIB; WATER;

ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG STABILITY; INTERFACE PRESSURE; IONIZATION; LIQUID CHROMATOGRAPHY; MEASUREMENT ACCURACY; POSITIVE ION ELECTROSPRAY; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; REACTION ANALYSIS; TANDEM MASS SPECTROMETRY;

EID: 84880967002     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2013.06.030     Document Type: Article

References (12)

1. Torrance C.J., Jackson P.E., Montgomery E., Kinzler K.W., Vogelstein B., Wissner A., Nunes M., Frost P., Discafani C.M. Nat. Med. 2000, 6:1024.
2. Nunes M., Shi C., Greenberger L.M. Mol. Cancer Ther. 2004, 3:21.
3. Salomon D.S., Brandt R., Ciardiello F., Normanno N. Crit. Rev. Oncol. Hematol. 1995, 19:183.
4. Erlichman C., Hidalgo M., Boni J.P., Martins P., Quinn S.E., Zacharchuk C., Amorusi P., Adjei A.A., Rowinsky E.K. J. Clin. Oncol. 2006, 24:2252.
5. Allison M. Nat. Biotechnol. 2010, 28:999.
6. Laheru D., Croghan G., Bukowski R., Rudek M., Messersmith W., Erlichman C., Pelley R., Jimeno A., Donehower R., Boni J., Abbas R., Martins P., Zacharchuk C., Hidalgo M. Clin. Cancer Res. 2008, 14:5602.
7. Center for Drug Evaluation and Research of the U.S. Department of Health and Human Services Food and Drug Administration, 2001, (accessed 25.02.13). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf.
8. European Medicines Agency, 2009, (accessed 25.02.13). http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/12/WC500018062.pdf.
9. Sparidans R.W., Ahmed T.T., Muilwijk E.W., Welzen M.E., Schellens J.H., Beijnen J.H. J. Chromatogr. B. Anal. Technol. Biomed. Life Sci. 2012, 905:137.
10. Sparidans R.W., Tang S.C., Nguyen L.N., Schinkel A.H., Schellens J.H., Beijnen J.H. J. Chromatogr. B. Anal. Technol. Biomed. Life Sci. 2012, 905:150.
11. Sparidans R.W., Iusuf D., Schinkel A.H., Schellens J.H., Beijnen J.H. J. Chromatogr. B. Anal. Technol. Biomed. Life Sci. 2009, 877:4090.
12. Folprecht G., Tabernero J., Kohne C.H., Zacharchuk C., Paz-Ares L., Rojo F., Quinn S., Casado E., Salazar R., Abbas R., Lejeune C., Marimon I., Andreu J., Ubbelohde U., Cortes-Funes H., Baselga J. Clin. Cancer Res. 2008, 14:215.